Clinical Evaluation of Lapatinib Administered With Capecitabine in Japanese Patients With ErbB2 Overexpressing Advanced or Metastatic Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 16 Sep 2011
At a glance
- Drugs Capecitabine; Lapatinib
- Indications Advanced breast cancer
- Focus Adverse reactions; Biomarker; Therapeutic Use
- Sponsors GlaxoSmithKline
- 25 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Feb 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 21 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.